Members of the Pharmaceutical Product Working Group (PPWG) and the ASEAN Health Cluster 3 (AHC 3) made substantial progress on the development of the ASEAN Pharmaceutical Regulatory Framework. The two bodies have agreed that the draft document is now sufficiently developed to permit a final domestic consultation and pave the way for formal adoption.
The PPWG and AHC 3 represent Member States’ interest on the economic and health aspects of the pharmaceutical sector and are leading the development of a comprehensive market integration process for the pharmaceutical sector. The virtual event was held in 2 sessions on 7th & 8th December, 2021. This event follows the successful conclusion of deliberations on the ASEAN Pharmaceutical Regulatory Policy (APRP) by the same ASEAN bodies in October of this year. The APRP itself is now under review by senior officials in the Economic and Health sectors preceding a formal adoption by ASEAN Member States.
For more details, please visit News on Workshop on the ASEAN Pharmaceutical Regulatory Framework
